{"id":"https://openalex.org/W2333748686","doi":"https://doi.org/10.1248/cpb.34.1366","title":"Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone.","display_name":"Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone.","alternate_titles":[],"publication_year":1986,"publication_date":"1986-03-01","ids":{"openalex":"https://openalex.org/W2333748686","doi":"https://doi.org/10.1248/cpb.34.1366","mag":"2333748686","pmid":"https://pubmed.ncbi.nlm.nih.gov/3731351"},"language":"en","primary_location":{"id":"doi:10.1248/cpb.34.1366","doi":"https://doi.org/10.1248/cpb.34.1366","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.34.1366","pdf_url":"https://www.jstage.jst.go.jp/article/cpb1958/34/3/34_3_1366/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2333748686"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/cpb1958/34/3/34_3_1366/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060273600","display_name":"NAOMI FUKUDA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"NAOMI FUKUDA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023142780","display_name":"NAOYO HIGUCHI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"NAOYO HIGUCHI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111440183","display_name":"Masako Ohno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MASAKO OHNO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065166774","display_name":"HARUMI KENMOCHI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"HARUMI KENMOCHI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091748061","display_name":"Hitoshi Sekikawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"HITOSHI SEKIKAWA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5040667714","display_name":"Masahiko Takada","orcid":"https://orcid.org/0000-0003-0774-2333","observed_orcids":["https://orcid.org/0000-0003-0774-2333"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MASAHIKO TAKADA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.48,"has_fulltext":false,"cited_by_count":18,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.45934066,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"34","issue":"3","first_page":"1366","last_page":"1369"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prednisolone","display_name":"prednisolone","score":1.0},{"id":"https://openalex.org/keywords/solid-dispersion","display_name":"solid dispersion","score":0.734000027179718},{"id":"https://openalex.org/keywords/cyclodextrins","display_name":"cyclodextrins","score":0.9769999980926514},{"id":"https://openalex.org/keywords/polyvinylpyrrolidone","display_name":"polyvinylpyrrolidone","score":0.9660000205039978},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.9110000133514404},{"id":"https://openalex.org/keywords/spray-drying","display_name":"spray drying","score":0.7919999957084656},{"id":"https://openalex.org/keywords/crystallization-inhibition","display_name":"crystallization suppression","score":0.8230000138282776},{"id":"https://openalex.org/keywords/stability-constants","display_name":"stability constants","score":0.6949999928474426},{"id":"https://openalex.org/keywords/drug-polymer-interactions","display_name":"drug-polymer interactions","score":0.7020000219345093},{"id":"https://openalex.org/keywords/beta-cyclodextrin","display_name":"\u03b2-cyclodextrin","score":0.8149999976158142},{"id":"https://openalex.org/keywords/gamma-cyclodextrin","display_name":"\u03b3-cyclodextrin","score":1.0}],"concepts":[{"id":"https://openalex.org/C2780077769","wikidata":"https://www.wikidata.org/wiki/Q413433","display_name":"Polyvinylpyrrolidone","level":2,"score":0.9116390943527222},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.9046928882598877},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.8004980087280273},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8001995086669922},{"id":"https://openalex.org/C177562468","wikidata":"https://www.wikidata.org/wiki/Q182893","display_name":"Dispersion (optics)","level":2,"score":0.6595422029495239},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.451462060213089},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.45123347640037537},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4410381317138672},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.19837415218353271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.05929556488990784},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.05034264922142029},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D003912","descriptor_name":"Dextrins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D011205","descriptor_name":"Povidone","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013213","descriptor_name":"Starch","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/cpb.34.1366","doi":"https://doi.org/10.1248/cpb.34.1366","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.34.1366","pdf_url":"https://www.jstage.jst.go.jp/article/cpb1958/34/3/34_3_1366/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:3731351","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3731351","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/cpb.34.1366","doi":"https://doi.org/10.1248/cpb.34.1366","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.34.1366","pdf_url":"https://www.jstage.jst.go.jp/article/cpb1958/34/3/34_3_1366/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2333748686.pdf","grobid_xml":"https://content.openalex.org/works/W2333748686.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2765824352","https://openalex.org/W2129509912","https://openalex.org/W2128413843","https://openalex.org/W1585593376","https://openalex.org/W1993347169","https://openalex.org/W2321907259","https://openalex.org/W1964437720","https://openalex.org/W2368759911","https://openalex.org/W1978040798","https://openalex.org/W2014390215"],"abstract_inverted_index":{"Solid":[0],"dispersion":[1,26,40],"systems":[2,27,41,73],"of":[3,18,42,49,53,68,79],"prednisolone-cyclodextrins":[4],"(CD)":[5],"and":[6,57,71],"prednisolone-polyvinyl-pyrrolidone":[7],"(PVP)":[8],"were":[9,20,74],"prepared":[10],"by":[11],"the":[12,29,38,47,69,80],"spray-drying":[13],"method.":[14],"The":[15,51,64],"dissolution":[16],"rates":[17],"prednisolone":[19,54],"markedly":[21],"increased":[22],"in":[23,28,59],"these":[24],"solid":[25,39],"pharmacopeial":[30],"disintegration":[31],"medium":[32],"at":[33],"pH":[34],"6.8.":[35],"In":[36],"particular,":[37],"prednisolone-CD":[43],"inhibited":[44],"and/or":[45],"retarded":[46],"crystallization":[48],"prednisolone.":[50],"interaction":[52],"with":[55],"CD":[56],"PVP":[58,81],"water":[60],"was":[61],"also":[62],"investigated.":[63],"apparent":[65],"stability":[66],"constants":[67],"\u03b2-":[70],"\u03b3-CD":[72],"both":[75],"larger":[76],"than":[77],"that":[78],"system.":[82]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2333748686","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
